Anti-RAB9A monoclonal antibody

Pre-made anti-RAB9A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RAB9A/RAB9A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T66350-Ab-1/ GM-Tg-hg-T66350-Ab-2Anti-Human RAB9A monoclonal antibodyHuman
GM-Tg-rg-T66350-Ab-1/ GM-Tg-rg-T66350-Ab-2Anti-Rat RAB9A monoclonal antibodyRat
GM-Tg-mg-T66350-Ab-1/ GM-Tg-mg-T66350-Ab-2Anti-Mouse RAB9A monoclonal antibodyMouse
GM-Tg-cynog-T66350-Ab-1/ GM-Tg-cynog-T66350-Ab-2Anti-Cynomolgus/ Rhesus macaque RAB9A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T66350-Ab-1/ GM-Tg-felg-T66350-Ab-2Anti-Feline RAB9A monoclonal antibodyFeline
GM-Tg-cang-T66350-Ab-1/ GM-Tg-cang-T66350-Ab-2Anti-Canine RAB9A monoclonal antibodyCanine
GM-Tg-bovg-T66350-Ab-1/ GM-Tg-bovg-T66350-Ab-2Anti-Bovine RAB9A monoclonal antibodyBovine
GM-Tg-equg-T66350-Ab-1/ GM-Tg-equg-T66350-Ab-2Anti-Equine RAB9A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T66350-Ab-1/ GM-Tg-hg-T66350-Ab-2; GM-Tg-rg-T66350-Ab-1/ GM-Tg-rg-T66350-Ab-2;
GM-Tg-mg-T66350-Ab-1/ GM-Tg-mg-T66350-Ab-2; GM-Tg-cynog-T66350-Ab-1/ GM-Tg-cynog-T66350-Ab-2;
GM-Tg-felg-T66350-Ab-1/ GM-Tg-felg-T66350-Ab-2; GM-Tg-cang-T66350-Ab-1/ GM-Tg-cang-T66350-Ab-2;
GM-Tg-bovg-T66350-Ab-1/ GM-Tg-bovg-T66350-Ab-2; GM-Tg-equg-T66350-Ab-1/ GM-Tg-equg-T66350-Ab-2
Products NameAnti-RAB9A monoclonal antibody
Formatmab
Target NameRAB9A
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RAB9A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T66350-Ag-1Recombinant multi-species RAB9A/ RAB9 protein
    ORF Viral VectorvGMLP004170human RAB9A Lentivirus particle
    ORF Viral VectorpGMLP004170human RAB9A Lentivirus plasmid
    ORF Viral VectorpGMLV000620house mouse Rab9 Lentivirus plasmid
    ORF Viral VectorpGMLPm003335mouse Rab9 Lentivirus plasmid
    ORF Viral VectorvGMLV000620house mouse Rab9 Lentivirus particle
    ORF Viral VectorvGMLPm003335mouse Rab9 Lentivirus particle


    Target information

    Target IDGM-T66350
    Target NameRAB9A
    Gene ID9367,56382,84589,720906,403947,101089079,511776,100050487
    Gene Symbol and Synonyms2410064E05Rik,RAB9,RAB9A,Sid6061p
    Uniprot AccessionP51151,Q99P75,P24408
    Uniprot Entry NameRAB9A_HUMAN,RAB9A_RAT,RAB9A_CANLF
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000123595
    Target ClassificationN/A

    The target: RAB9A, gene name: RAB9A, also named as RAB9. Enables GDP binding activity; GTP binding activity; and GTPase activity. Involved in negative regulation by host of symbiont catalytic activity; positive regulation of exocytosis; and regulation of protein localization. Located in late endosome; lysosome; and phagocytic vesicle. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.